Christine Murray
Conseiller Juridique Général chez CYTOKINETICS, INCORPORATED
Fortune : 1 116 $ au 30/04/2024
Postes actifs de Christine Murray
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CYTOKINETICS, INCORPORATED | Conseiller Juridique Général | 01/04/2023 | - |
Historique de carrière de Christine Murray
Anciens postes connus de Christine Murray
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 07/01/2019 | 15/03/2024 |
| Independent Dir/Board Member | 07/01/2019 | 15/03/2024 | |
| ULTRAGENYX PHARMACEUTICAL INC. | Conseiller Juridique Général | 01/07/2018 | 01/09/2021 |
Raptor Pharmaceuticals, Inc.
 Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Corporate Officer/Principal | 01/01/2015 | 01/02/2017 |
| RAPTOR PHARMACEUTICAL CORP | Conseiller Juridique Général | 01/03/2015 | 01/01/2017 |
| ACHAOGEN | Conseiller Juridique Général | 01/08/2011 | 02/01/2015 |
Formation de Christine Murray
| The University of Liverpool | Undergraduate Degree |
| Newcastle University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Royaume-Uni | 3 |
Opérationnelle
| General Counsel | 4 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| Entreprise privées | 3 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA. | Health Technology |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Health Technology |
- Bourse
- Insiders
- Christine Murray
- Expérience